See All Slides - tctmd.com

Slides

Presentation TCT 2013

Two Illustrative Cases: One Simple PDA and One More Complex (Hypertensive)

Presenter: Carlos Pedra

October 30, 2013

Presentation TCT 2013

BVS in Long Lesions: How to Overlap (With Case Examples)

Presenter: Robert Welsh

October 30, 2013

Presentation TCT 2013

Motion: All Patients with Multivessel Disease and Impaired Left Ventricular Function Should Undergo Revascularization - Against: Revascularization Should be Reserved for Patient...

Presenter: Rita Redberg

October 30, 2013

Presentation TCT 2013

Carotid Stenting Randomized Trials Redux: ACST2, SPACE 2, and CREST2

Presenter: Alison Halliday

October 30, 2013

Presentation TCT 2013

MitraClip Patient Selection for FMR II. Identifying Appropriate Patients

Presenter: Anita Asgar

October 30, 2013

Presentation TCT 2013

Hybrid Strategies for Treatment of Aortic Arch Pathologies

Presenter: Wilson Szeto

October 30, 2013

Presentation TCT 2013

Case Presentation: Paravalvular AR After TAVR

Presenter: Femi Philip

October 30, 2013

Presentation TCT 2013

The Great Debate: Does It Make Sense to Search and Destroy Focal Vulnerable Plaque? No! A Futile, Expensive, and Risky Enterprise!

Presenter: John Ambrose

October 30, 2013

Presentation TCT 2013

FDA-CDRH Perspectives

Presenter: Matthew Hillebrenner

October 30, 2013

Presentation TCT 2013

IVUS Guidance During PCI to Reduce Contrast Use: The MOZART Randomized Study

Presenter: Pedro Lemos

October 30, 2013

Advertisement

Slides

Two Illustrative Cases: One Simple PDA and One More Complex (Hypertensive)

BVS in Long Lesions: How to Overlap (With Case Examples)

Motion: All Patients with Multivessel Disease and Impaired Left Ventricular Function Should Undergo Revascularization - Against: Revascularization Should be Reserved for Patient...

Carotid Stenting Randomized Trials Redux: ACST2, SPACE 2, and CREST2

MitraClip Patient Selection for FMR II. Identifying Appropriate Patients

Hybrid Strategies for Treatment of Aortic Arch Pathologies

Case Presentation: Paravalvular AR After TAVR

The Great Debate: Does It Make Sense to Search and Destroy Focal Vulnerable Plaque? No! A Futile, Expensive, and Risky Enterprise!

FDA-CDRH Perspectives

IVUS Guidance During PCI to Reduce Contrast Use: The MOZART Randomized Study

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content